Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Revvity Omics, |
RCV003490456 | SCV004234226 | uncertain significance | Hereditary spherocytosis type 1 | 2023-07-25 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004364864 | SCV004899267 | uncertain significance | Inborn genetic diseases | 2022-01-26 | criteria provided, single submitter | clinical testing | The c.2234G>A (p.G745E) alteration is located in exon 20 (coding exon 20) of the ANK1 gene. This alteration results from a G to A substitution at nucleotide position 2234, causing the glycine (G) at amino acid position 745 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |